These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 33316261)

  • 1. Potential Functional Restoration of Corneal Endothelial Cells in Fuchs Endothelial Corneal Dystrophy by ROCK Inhibitor (Ripasudil).
    Schlötzer-Schrehardt U; Zenkel M; Strunz M; Gießl A; Schondorf H; da Silva H; Schmidt GA; Greiner MA; Okumura N; Koizumi N; Kinoshita S; Tourtas T; Kruse FE
    Am J Ophthalmol; 2021 Apr; 224():185-199. PubMed ID: 33316261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Migration of Fuchs Corneal Endothelial Cells by Rho Kinase Inhibition: A Novel Ex Vivo Descemet's Stripping Only Model.
    Parekh M; Miall A; Chou A; Buhl L; Deshpande N; Price MO; Price FW; Jurkunas UV
    Cells; 2024 Jul; 13(14):. PubMed ID: 39056800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Descemet Stripping Only Supplemented With Topical Ripasudil for Fuchs Endothelial Dystrophy 12-Month Outcomes of the Sydney Eye Hospital Study.
    Moloney G; Garcerant Congote D; Hirnschall N; Arsiwalla T; Luiza Mylla Boso A; Toalster N; D'Souza M; Devasahayam RN
    Cornea; 2021 Mar; 40(3):320-326. PubMed ID: 32740006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells.
    Okumura N; Okazaki Y; Inoue R; Nakano S; Fullwood NJ; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7560-7. PubMed ID: 26618648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Topical Rho Kinase Inhibitors in the Treatment of Fuchs Dystrophy After Descemet Stripping Only.
    Macsai MS; Shiloach M
    Cornea; 2019 May; 38(5):529-534. PubMed ID: 30720541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descemetorhexis Without Grafting for Fuchs Endothelial Dystrophy-Supplementation With Topical Ripasudil.
    Moloney G; Petsoglou C; Ball M; Kerdraon Y; Höllhumer R; Spiteri N; Beheregaray S; Hampson J; DʼSouza M; Devasahayam RN
    Cornea; 2017 Jun; 36(6):642-648. PubMed ID: 28476048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo excimer laser ablation of cornea guttata and ROCK inhibitor-aided endothelial recolonization of ablated central cornea.
    Kassumeh S; von Studnitz A; Priglinger SG; Fuchshofer R; Luft N; Moloney G; Dirisamer M; Ohlmann A
    Acta Ophthalmol; 2020 Sep; 98(6):e773-e780. PubMed ID: 32017400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descemet Endothelial Thickness Comparison Trial II (DETECT II): multicentre, outcome assessor-masked, placebo-controlled trial comparing Descemet membrane endothelial keratoplasty (DMEK) to Descemet stripping only (DSO) with adjunctive ripasudil for Fuchs dystrophy.
    Lin CC; Chamberlain W; Benetz BA; Gensheimer W; Li JY; Jeng BH; Clover J; Varnado N; Abdelrahman S; Srinivasan A; Syed ZA; Koo EH; Arnold BF; Lietman TM; Lass J; Rose-Nussbaumer J
    BMJ Open Ophthalmol; 2024 Oct; 9(1):. PubMed ID: 39353677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culture of corneal endothelial cells obtained by descemetorhexis of corneas with Fuchs endothelial corneal dystrophy.
    Bertolin M; Lamon M; Franco E; Barbaro V; Ferrari S; Bovone C; Yu AC; Parekh M; Ponzin D; Busin M
    Exp Eye Res; 2021 Oct; 211():108748. PubMed ID: 34461137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease.
    Syed ZA; Rapuano CJ
    Curr Opin Ophthalmol; 2021 May; 32(3):268-274. PubMed ID: 33606407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the Gutta-Induced Microenvironment With Corneal Endothelial Cell Behavior and Demise in Fuchs Endothelial Corneal Dystrophy.
    Kocaba V; Katikireddy KR; Gipson I; Price MO; Price FW; Jurkunas UV
    JAMA Ophthalmol; 2018 Aug; 136(8):886-892. PubMed ID: 29852040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Corneal Endothelial Cell Migration in Fuchs Endothelial Corneal Dystrophy: A Live Cell Imaging Study.
    Ong Tone S; Wylegala A; Böhm M; Melangath G; Deshpande N; Jurkunas UV
    Ophthalmol Sci; 2021 Mar; 1(1):100006. PubMed ID: 36246012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty.
    Wang Z; Handa JT; Green WR; Stark WJ; Weinberg RS; Jun AS
    Ophthalmology; 2007 Aug; 114(8):1453-60. PubMed ID: 17320180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Matrix and Integrin Expression Profiles in Fuchs Endothelial Corneal Dystrophy Cells and Tissue Model.
    Goyer B; Thériault M; Gendron SP; Brunette I; Rochette PJ; Proulx S
    Tissue Eng Part A; 2018 Apr; 24(7-8):607-615. PubMed ID: 28726551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Impact of Fibronectin, Tenascin-C, Osteopontin, and Type XIV Collagen in Fuchs Endothelial Corneal Dystrophy.
    Tchatchouang A; Brunette I; Rochette PJ; Proulx S
    Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):38. PubMed ID: 38656280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor 4 promotes increased corneal endothelial cellular migration by altering microtubules in Fuchs endothelial corneal dystrophy.
    Yan J; Mehta S; Patel K; Dhupar N; Little N; Ong Tone S
    Sci Rep; 2024 May; 14(1):10276. PubMed ID: 38704483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Descemet Endothelial Thickness Comparison Trial 1 (DETECT 1): outcome masked, placebo-controlled trial comparing two types of corneal transplant surgeries and effect of rho kinase inhibitors on endothelial cell loss protocol.
    Chamberlain W; Lin CC; Li JY; Gensheimer W; Clover J; Jeng BH; Varnado N; Abdelrahman S; Arnold BF; Lietman TM; Rose-Nussbaumer J
    BMJ Open Ophthalmol; 2024 Jan; 9(1):. PubMed ID: 38286566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing.
    Okumura N; Okazaki Y; Inoue R; Kakutani K; Nakano S; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1284-92. PubMed ID: 26998714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulforaphane decreases endothelial cell apoptosis in fuchs endothelial corneal dystrophy: a novel treatment.
    Ziaei A; Schmedt T; Chen Y; Jurkunas UV
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6724-34. PubMed ID: 24030461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Culture of human corneal endothelial cells isolated from corneas with Fuchs endothelial corneal dystrophy.
    Zaniolo K; Bostan C; Rochette Drouin O; Deschambeault A; Perron MC; Brunette I; Proulx S
    Exp Eye Res; 2012 Jan; 94(1):22-31. PubMed ID: 22134119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.